NCT03308929 is a clinical trial of G7 Dual Mobility hip in Clinical Outcomes, sponsored by Zimmer Biomet.

Who is sponsoring NCT03308929?

NCT03308929 is sponsored by Zimmer Biomet.

What drugs are being tested in NCT03308929?

Interventions in NCT03308929: G7 Dual Mobility hip.

What condition does NCT03308929 study?

NCT03308929 studies Clinical Outcomes, Functional Outcomes, Radiological Outcomes, Survivorship, Safety.

Is NCT03308929 still recruiting?

NCT03308929 is currently active, enrolled. Last updated 15 June 2025.

Last reviewed 2025-06-15 · How we verify

NCT03308929

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective G7 Dual Mobility Total Hip PMCF

Active, enrolled Last updated 15 June 2025

What this trial tests

trial testing G7 Dual Mobility hip in Clinical Outcomes in 250 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

28 February 2017

Primary endpoint
1 July 2027

28 February 2029

Quick facts

Lead sponsor	Zimmer Biomet
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	250
Start date	28 February 2017
Primary completion	1 July 2027
Estimated completion	28 February 2029
Sites	6 locations across United States

Drugs / interventions tested

G7 Dual Mobility hip

Conditions studied

Clinical Outcomes — all drugs for Clinical Outcomes →
Functional Outcomes — all drugs for Functional Outcomes →
Radiological Outcomes — all drugs for Radiological Outcomes →
Survivorship — all drugs for Survivorship →

Sponsor

Zimmer Biomet — full company profile →

Who can join

Adults 18 to 80, any sex, with Clinical Outcomes or Functional Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective multi-center clinical evaluation following recipients of the G7 Dual Mobility hip device. The primary objective is to characterize survivorship of the G7 hip at five years post-index procedure. Secondary objectives include documentation of clinical outcomes, safety and radiographic data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clinical Outcomes

Currently open trials in the same condition.

NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
NCT07323355 — Single- vs Double-Layer Cesarean Scar Repair and Myometrial Thickness · NA · recruiting
NCT07488416 — Clinical and Radiographic Outcomes of Lesion Sterilization and Tissue Repair Using Zinc Oxide/ 6-gingerol Mix Versus Tri · NA · recruiting
NCT06219083 — Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM) · recruiting

Other Zimmer Biomet trials

Trials by the same sponsor.

NCT06287853 — Tapestry Rotator Cuff Repair PMCF · suspended
NCT06863428 — Mymobility Knee ROM · recruiting
NCT06920459 — Zimmer Biomet Shoulder Arthroplasty PMCF Study · recruiting
NCT07009912 — ROSA® Knee System V1.5 Pilot Study · NA · completed
NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03308929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zimmer Biomet
Last refreshed: 15 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03308929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing